Muhammad Adrish is a Respiratory physician affiliated with Baylor College of Medicine. OpenAlex indexes 93 publications with 721 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1504 Taub Loop
Houston, TX 770301608
Telephone
713-873-8890Provider last certified this registry record 30 Apr 2026.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20241 payment
- AstraZeneca Pharmaceuticals LPProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
97.8%Corticosteroid36.8%Symbicort34%Fluticasone Propionate32%Breo Ellipta22%Flovent Hfa12%Part D<11 patientsbeta2-Adrenergic Agonist32.5%Albuterol Sulfate Hfa100%Part D≥56 patients+ 2 more classes in this area
Metabolism & gastrointestinal
2.2%Corticosteroid2.2%Prednisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Established and Emerging Asthma Biomarkers with a Focus on Biologic Trials: A Narrative Review
Journal of Personalized Medicine
2025 - Benralizumab Adherence Reduces Exacerbations and Exacerbation-related Medical Costs Among Patients With Severe Asthma: Results from the Zephyr-5 Study
American Journal of Respiratory and Critical Care Medicine
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Christie Ballantyne, MD
Baylor College of Medicine
Biykem Bozkurt, MD
Baylor College of Medicine
William Mitch, MD
Baylor College of Medicine
Garabed Eknoyan, MD
Baylor College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”